Greencoat Renewables Regulatory News (GRP)

Greencoat Renewables proposed secondary listing on the Johannesburg Stock Exchange

Dublin, London | 13 May 2025: Greencoat Renewables PLC ("Greencoat", "the Company" or "GRP"), the renewable energy infrastructure company investing in European renewable energy generation assets, is in the process of applying for a secondary inward listing on the Alternative Exchange of the Johannesburg Stock Exchange ("JSE") by way of an introduction.

The Company has received strong interest in the listing from a number of South African institutional investors, attracted to GRP's scale, strong track record, high cash generation and progressive approach to distributions.

GRP believes that admission to trading of its shares on the JSE will be beneficial to the Company and its stakeholders as it will enhance liquidity for shareholders, diversify the Company's shareholder base and position Greencoat for growth, by providing access to a new and deep capital market.

The listing of GRP on the JSE is expected to become effective later this year, subject to the necessary regulatory approvals in South Africa which are well advanced. The Company will not place or issue any new GRP shares as part of the listing and will remain listed on the Euronext Growth Market in Dublin and the Alternative Investment Market in London.

Valeo Capital Proprietary Limited has been appointed as sole Corporate Advisor and JSE Sponsor for the listing.

Ronan Murphy, Non-Executive Chairman of Greencoat Renewables, said:

"We are pleased to announce that, following detailed consideration, we are in the process of applying for an additional listing on the JSE. We have been encouraged by the response of highly reputable South African institutional investors, and expect to increase liquidity, broaden the Company's shareholder base and position it for future growth in due course. Through the continued generation of high and secure cashflows, we consider the Company well placed to provide local investors with attractive Euro-denominated returns going forward".

For further information: